FDA MedWatch – Lipodrene with 25 mg Ephedra Extract Dietary Supplement by Hi-Tech Pharmaceuticals: Recall

TOPIC: Lipodrene with 25 mg Ephedra Extract Dietary Supplement by Hi Tech Pharmaceuticals: Recall – Due to the Presence of 1,4-dimethylamylamine (DMAA)

AUDIENCE: Consumer, Health Professional

ISSUE: Hi-Tech Pharmaceuticals Inc. is recalling Lipodrene with 25 mg Ephedra Extract Dietary Supplement Lot # 001211197, Exp. 12/25 due to the presence of 1,4-dimethylamylamine (DMAA). The FDA has warned that DMAA is dangerous because it can narrow blood vessels and arteries and cause a corresponding rise in blood pressure or other cardiovascular problems, such as: shortness of breath, arrhythmias, elevated blood pressure, tightening in the chest, and heart attack.

For more information about this recall, click on the red button “Read Recall” below.

BACKGROUND: The product is being marketed as a weight loss aid. 

RECOMMENDATIONS: 

Health professionals and consumers are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

• Complete and submit the report online.
• Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on form, or submit by fax to 1-800-FDA-0178.